Back
Black Diamond Therapeutics Stock Price Chart
Sponsored
BDTX
Sponsored
This DeFi Coin Could 10x Soon... I Advise You Get In Now!
Discover this DeFi diamond before the next surge
Sell
47
BDTX
Black Diamond Therapeutics
Last Price:
5.74
Seasonality Move:
25.38%
7 Day Trial
ALL ACCESS PASS
$
7
BREAKING: Elon Musk's Secret A.I. Project Set to Plunge Millions of Americans Into Poverty
Click here now to prepare yourself for what's around the corner- The current trend is moderately bearish and BDTX is experiencing selling pressure, which indicates risk of future bearish movement.
Black Diamond Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 6.74 | Sell |
20-day SMA: | 5.95 | Sell |
50-day SMA: | 5.28 | Buy |
200-day SMA: | 3.6 | Buy |
8-day EMA: | 6.4 | Sell |
20-day EMA: | 6.07 | Sell |
50-day EMA: | 5.42 | Buy |
200-day EMA: | 3.99 | Buy |
Black Diamond Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.39 | Buy |
Relative Strength Index (14 RSI): | 50.64 | Buy |
Chaikin Money Flow: | -300067 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (5.08 - 6.54) | Buy |
Bollinger Bands (100): | (3.25 - 5.63) | Buy |
Black Diamond Therapeutics Technical Analysis
Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Black Diamond Therapeutics Stock
Is Black Diamond Therapeutics Stock a Buy?
- Black Diamond Therapeutics share price is 5.94 while BDTX 8-day simple moving average is 6.74, which is a Sell signal.
- The stock price of BDTX is 5.94 while Black Diamond Therapeutics 20-day SMA is 5.95, which makes it a Sell.
- Black Diamond Therapeutics 50-day simple moving average is 5.28 while BDTX share price is 5.94, making it a Buy technically.
- BDTX stock price is 5.94 and Black Diamond Therapeutics 200-day simple moving average is 3.60, creating a Buy signal.
BDTX Technical Analysis vs Fundamental Analysis
Sell
47
Black Diamond Therapeutics (BDTX)
is a Sell
Is Black Diamond Therapeutics a Buy or a Sell?
-
Black Diamond Therapeutics stock is rated a Sell
The current Black Diamond Therapeutics [BDTX] share price is $5.94. The Score for BDTX is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
Black Diamond Therapeutics Stock Info
Market Cap:
334.14M
Price in USD:
5.94
Share Volume:
424.23K
Black Diamond Therapeutics 52-Week Range
52-Week High:
7.66
52-Week Low:
1.57
Sell
47
Black Diamond Therapeutics (BDTX)
is a Sell
Black Diamond Therapeutics Share Price Forecast
-
What is the Black Diamond Therapeutics stock price today?
The Black Diamond Therapeutics stock price is 5.94 USD today. -
Will BDTX stock go up or go down?
Black Diamond Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Black Diamond Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Black Diamond Therapeutics is overvalued.
Is Black Diamond Therapeutics Stock a Buy?
- Black Diamond Therapeutics share price is 5.94 while BDTX 8-day exponential moving average is 6.40, which is a Sell signal.
- The stock price of BDTX is 5.94 while Black Diamond Therapeutics 20-day EMA is 6.07, which makes it a Sell.
- Black Diamond Therapeutics 50-day exponential moving average is 5.42 while BDTX share price is 5.94, making it a Buy technically.
- BDTX stock price is 5.94 and Black Diamond Therapeutics 200-day simple moving average is 3.99, creating a Buy signal.
Fundamental Analysis of Black Diamond Therapeutics
Is Black Diamond Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.16 per share, an increase this year of $0.51 per share, and a decrease next year of $0.19 per share.
Technical Analysis of Black Diamond Therapeutics
Should I short Black Diamond Therapeutics stock?
- BDTX Moving Average Covergence Divergence (MACD) indicator is 0.39, suggesting Black Diamond Therapeutics is a Buy
- Black Diamond Therapeutics Relative Strength Index (RSI) is 50.64, which suggest Black Diamond Therapeutics is overbought
- The Bollinger Bands (25) for Black Diamond Therapeutics is (5.08 - 6.54), which suggest Black Diamond Therapeutics is a Buy
- The Bollinger Bands (100) for Black Diamond Therapeutics is (3.25 - 5.63), which suggest Black Diamond Therapeutics is a Buy
* Black Diamond Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.